FDA 483 - KEDPLASMA LLC - December 16, 2025

An FDA inspection of KEDPLASMA LLC in Indianapolis, IN, revealed two significant observations. The firm was cited for failing to include the total volume of plasma on Source Plasma container labels. Additionally, an observation was made regarding a phlebotomist's failure to maintain aseptic technique during arm preparation, leading to potential contamination.